Recommended Immunizations for a 23-Year-Old Female with Ulcerative Colitis on Remicade
For a 23-year-old female with ulcerative colitis on Remicade (infliximab), all three vaccines mentioned (Prevnar, Tdap, and Gardasil) are strongly recommended based on current guidelines. 1
Core Recommended Vaccines
Pneumococcal Vaccine (Prevnar)
- Strongly recommended for patients with IBD on immunosuppressive therapy like Remicade 1
- The Canadian Association of Gastroenterology recommends pneumococcal vaccines for adult IBD patients on immunosuppressive therapy (conditional recommendation, low certainty of evidence) 1
- Patients on biologics like Remicade are considered immunosuppressed and at higher risk for pneumococcal infections
Tetanus, Diphtheria, and Pertussis (Tdap)
- Strongly recommended for all adult patients with IBD (strong recommendation, moderate certainty of evidence) 1
- Should be administered regardless of immunosuppression status
- Particularly important for patients on biologics to maintain protection against these infections
Human Papillomavirus (Gardasil)
- Strongly recommended for female patients with IBD aged 9-26 years (strong recommendation, moderate certainty of evidence) 1
- This patient at 23 years falls within the recommended age range
- Particularly important as immunosuppressed patients may have higher risk of HPV-related complications
Additional Recommended Vaccines
Influenza Vaccine
- Annual influenza vaccination is strongly recommended for all adult IBD patients (strong recommendation, moderate certainty of evidence) 1
- Should be administered regardless of timing relative to Remicade infusions (no consensus on optimal timing) 1
Hepatitis B Vaccine
- Recommended for all unimmunized adult IBD patients, even without specific risk factors (conditional recommendation, low certainty of evidence) 1
- Should check serology first to determine vaccination status
Recombinant Zoster Vaccine
- Consider for adults with IBD younger than 50 years (conditional recommendation, low certainty of evidence) 1
- Non-live zoster vaccine is safe in immunosuppressed patients
Implementation Considerations
- All these vaccines are inactivated and safe to administer to patients on Remicade
- Ideally, vaccination status should be assessed at diagnosis of IBD, before starting immunosuppressive therapy
- Vaccine response may be suboptimal while on Remicade, but benefits outweigh risks
- No need to time vaccinations with Remicade infusion schedule (no consensus on optimal timing) 1
Common Pitfalls to Avoid
- Delaying vaccination due to concerns about IBD flares (inactivated vaccines do not trigger disease flares)
- Assuming primary care providers have addressed vaccination needs
- Waiting for disease remission before vaccinating (may miss opportunity to protect patient)
- Forgetting to check vaccination status before initiating immunosuppressive therapy
The evidence strongly supports administering all three vaccines mentioned (Prevnar, Tdap, and Gardasil) to this 23-year-old female with ulcerative colitis on Remicade, as they are all inactivated vaccines that are safe and recommended for patients on immunosuppressive therapy.